Pulsatile release of valsartan

Details for Australian Patent Application No. 2009256423 (hide)

Owner Novartis AG

Inventors Taillardat, Agnes; Wagner, Robert Frank; Matharu, Amol Singh

Agent Davies Collison Cave

Pub. Number AU-A-2009256423

PCT Pub. Number WO2009/148990

Priority 61/058,233 03.06.08 US

Filing date 1 June 2009

Wipo publication date 10 December 2009

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/148990 Priority application(s): WO2009/148990

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256424-Children's ride-on vehicles having mechanical assemblies

2009256419-Decorative composition and method of using it